Related Experiment Video

Updated: Jul 11, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Myocardial infarction after meningococcal infection: a potential inflammatory link or a challenging puzzle?

Alexandre Leite de Souza, Jaques Sztajnbok, Antonio Carlos Seguro

    International Journal of Cardiology
    |September 15, 2007
    PubMed

    Insights

    Infectious diseases and systemic inflammation increase vascular event risk, like myocardial infarction. Further research into infection

    Area of Science:

    • Cardiovascular Science
    • Infectious Disease Research
    • Immunology

    Background:

    • Systemic inflammatory response and infections are linked to increased vascular events, including stroke and myocardial infarction.
    • The role of infections in triggering cardiovascular phenomena is often underreported and underexplored.
    • Advances in understanding cytokine networks and Toll-like receptor 4 (TLR4) have shed light on vascular inflammation and coronary artery disease.

    Discussion:

    • Meningococcal sepsis exemplifies how infections induce a significant host inflammatory response, involving cytokines, chemokines, complement, and nitric oxide pathways.
    • The precise mechanisms and pathogenic links through which infections influence acute cardiovascular events remain incompletely understood.
    • Cytokine concentration analysis may offer a valuable method for assessing myocardial infarction pathophysiology during infectious processes.

    Key Insights:

    • Infections can precipitate serious cardiovascular events through complex inflammatory pathways.
    • Understanding the interplay between infection and the cardiovascular system is crucial for patient outcomes.
    • Cytokine profiling shows promise for diagnosing and managing cardiovascular complications of infections.

    Outlook:

    • Further research is needed to elucidate the exact mechanisms linking infection to cardiovascular events.
    • Developing targeted strategies based on inflammatory markers could reduce adverse cardiovascular outcomes.
    • This knowledge may lead to novel therapeutic interventions for patients with concurrent infections and cardiovascular disease.

    Related Concept Videos

    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
    Myocarditis II: Clinical Features and Diagnostic Tests01:27

    Myocarditis II: Clinical Features and Diagnostic Tests

    Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...